Detection of p53 gene mutations by single strand conformational polymorphism (SSCP) in human acute myeloid leukemia-derived cell lines

Leukemia Research

Volumn 26, Issue 2, 2002, Pages 207-214

  Fleckenstein, Diana S ^a   Uphoff, Cord C ^a   Drexler, Hans G ^a   Quentmeier, Hilmar ^a  

^a LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

Author keywords

p53 Mutation detection; Sequencing analysis; Single strand conformational polymorphism

Indexed keywords

CYTOKINE; PROTEIN P53;

ACUTE GRANULOCYTIC LEUKEMIA; AMINO ACID SUBSTITUTION; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CODON; CONTROLLED STUDY; GENE DELETION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

ACUTE DISEASE; BLOTTING, WESTERN; CELL DIVISION; CODON; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENES, P53; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-3; LEUKEMIA, MYELOID; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SEQUENCE DELETION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036139122     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(01)00107-2     Document Type: Article

References (54)

1. Characterization of the human p53 gene
2. Structural aspects of the p53 protein in relation to gene evolution
3. A comparison of the biological activities of wild-type and mutant p53
4. Mutations in the p53 gene occur in diverse human tumour types
5. p53: A frequent target for genetic abnormalities in lung cancer
6. p53: Oncogene or anti-oncogene?
7. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations
8. Flexibility: The key to p53 function?
9. Mutations of the p53 gene are involved in Ewing's sarcoma but not in neuroblastomas
10. p53 gene mutations in non-small cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features
11. p53 alterations in human leukemia-lymphoma cell lines: In vitro artifact or prerequisite for cell immortalization?
12. Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells
13. A conformation hypothesis for the suppressor and promoter functions of p53 in cell growth control and in cancer
14. Addition of fresh medium induces cell cycle and conformation changes in p53, a tumour suppressor protein
15. Thrombopoietin upregulates the promoter conformation of p53 in a proliferation-independent manner coincident with a decreased expression of Bax: Potential mechanisms for survival enhancing effects
16. Conformational change of p53 protein in growth factor-stimulated human myelogenous leukemia cells
17. A structural role for metal ions in the 'wild-type' conformation of the tumor suppressor protein p53
18. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms
19. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction
20. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products
21. Detection of aberrations of p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis
22. PCR-SSCP: A simple and sensitive method for detection of mutations in the genomic DNA
23. Mutations of p53 and human papillomavirus infection occur independently in cervical carcinoma
24. Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes
25. Establishment of a Ph-positive human cell line (BV173)
26. Establishment and characterization of a new permanent cell line (GDM-1) from a patient with myelomonoblastic leukemia
27. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia
28. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8; 21 chromosome translocation
29. Acute myelogenous leukemia: A human cell line responsive to colony-stimulating activity
30. Establishment of a novel human megakaryoblastic leukemia cell line, Meg-01, with positive Philadelphia chromosome
31. Malignant lymphoma of pre-T-cell type terminating in acute myelocytic leukemia
32. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes
33. Growth factor requirements of childhood acute leukemia: Establishment of GM-CSF-dependent cell lines
34. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3)
35. Establishment and characterization of a human acute monocytic leukemia cell line (THP1)
36. Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features
37. Establishment and characterization of a novel human immature megakaryoblastic leukemia cell line, M-MOK, dependent on fibroblasts for its viability
38. Identification and analysis of human erythropoietin receptors on a factor-dependent cell line, TF-1
39. The human bladder carcinoma cell line 5637 constitutively secretes functional cytokines
40. Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3
41. Expression of a retinoic acid gene in myeloid leukemia cells
42. Mast cell growth factor, a ligand for the receptor encoded by c-kit, affects the growth in culture of the blast cells of acute myeloblastic leukemia
43. Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36P: A parental line requiring granulocyte-macrophage colony-stimulating factor or interleukin-3, and a subline requiring erythropoietin
44. Cytokine-mediated erythroid maturation in megakaryoblastic human cell line HU-3
45. Establishment of a myeloid leukaemic cell line (SKNO-1) from a patient with t(8; 21) who acquired monosomy 17 during disease progression
46. Enhanced proliferative activity of PIXY-321, the granulocyte-macrophage colony-stimulating factor and interleukin-3 fusion protein
47. Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells
48. Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells
49. Frequent mutations in the p53 gene in human myeloid leukemia cell lines
50. Evolutionary conservation and somatic mutation hotspot maps of p53: Correlation with p53 protein structural and functional features
51. p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy
52. Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
53. Thrombopoietin-induced conformational change in p53 lies downstream of the p44/p42 mitogen activated protein kinase cascade in the human growth factor-dependent cell line M07e